Get the Stockscreener App
21.54
9.84%
1.93
Sanara Medtech Inc stock is traded at $21.54, with a volume of 108.35K.
It is up +9.84% in the last 24 hours and down -28.10% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$19.61
Open:
$19.61
24h Volume:
108.35K
Relative Volume:
3.03
Market Cap:
$191.76M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-41.42
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
-22.28%
1M Performance:
-28.10%
6M Performance:
-31.18%
1Y Performance:
-40.17%
1-Day Range:
$19.52
$22.65
1-Week Range:
$19.10
$29.20
52-Week Range:
$19.10
$38.75
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
21.54 | 175.23M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Sanara MedTech (SMTI) Receives Updated Analyst Rating and Price Target | SMTI Stock News - GuruFocus
Can Sanara MedTech Inc. stock rebound after recent weaknessTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Is Sanara MedTech Inc. stock gaining market shareMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
HC Wainwright & Co. Maintains Sanara MedTech (SMTI) Buy Recommendation - Nasdaq
Can Sanara MedTech Inc. stock sustain revenue growthMarket Movers & Fast Exit Strategy with Risk Control - newser.com
Best data tools to analyze Sanara MedTech Inc. stockTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Sanara MedTech Hits 52-Week Low at USD 21.07 Amid Ongoing Struggles - Markets Mojo
How strong is Sanara MedTech Inc. stock revenue growthJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Sanara MedTech (SMTI): Assessing Valuation After Strategic Shift and Quarterly Earnings Beat - Yahoo Finance
Can Sanara MedTech Inc. stock deliver consistent earnings growth2025 Market Overview & Fast Moving Trade Plans - newser.com
Sanara MedTech Inc. (NASDAQ:SMTI) Q3 2025 Earnings Call Transcript - MSN
Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted? - simplywall.st
Visualizing Sanara MedTech Inc. stock with heatmapsJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Sanara MedTech Reports Strong Q3 2025 Growth - TipRanks
Identifying reversal signals in Sanara MedTech Inc.2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
[10-Q] Sanara MedTech Inc. Quarterly Earnings Report | SMTI SEC FilingForm 10-Q - Stock Titan
Sanara MedTech Inc (SMTI) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Sanara MedTech Inc (SMTI) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Earnings call transcript: Sanara MedTech Q3 2025 sees revenue growth, stock up 3.1% - Investing.com Nigeria
Sanara MedTech Q3 2025 Earnings Call Transcript - MarketBeat
Sanara MedTech Inc. Initiates Strategic Realignment of its Business, Discontinuing Operations of its Tissue Health Plus - MarketScreener
Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus - MSN
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - Yahoo Finance
Sanara Medtech Bets On Core Surgery After Mixed Q3 Results - Finimize
SMTI Posts Strong Q3 Revenue Growth Driven by Surgical Sales - GuruFocus
Medical tech firm Sanara's Q3 revenue misses estimates after Tissue Health Plus unit closure - MarketScreener
Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited) - The Manila Times
[8-K] Sanara MedTech Inc. Reports Material Event | SMTI SEC FilingForm 8-K - Stock Titan
Sanara MedTech to Discontinue Tissue Health Plus Operations After Review - MarketScreener
Sanara MedTech (SMTI) Realigns Focus by Discontinuing THP Operat - GuruFocus
Sanara MedTech discontinues Tissue Health Plus segment - Investing.com
Sanara MedTech Inc. Completes Evaluation of Strategic Alternatives, Discontinues Tissue Health Plus Operations - Quiver Quantitative
Sanara MedTech (NASDAQ: SMTI) to classify THP as discontinued ops, wind-down through 2025 - Stock Titan
What To Expect From Sanara MedTech Inc (SMTI) Q3 2025 Earnings - GuruFocus
Sanara MedTech (SMTI) to Release Earnings on Wednesday - Defense World
Sanara MedTech showcases BIASURGE at TERMIS 2025 in Detroit - Traders Union
Sanara MedTech Inc. stock momentum explainedPortfolio Value Summary & Accurate Intraday Trade Tips - newser.com
What valuation multiples suggest for Sanara MedTech Inc. stockWeekly Investment Report & Entry Point Confirmation Signals - newser.com
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):